Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

35results about How to "Avoid depolymerization" patented technology

Biofilm formation to define risk for colon cancer

Methods of identifying subjects at increased risk of cancer, based upon detection of biofilms and / or biofilm-associated microbes within a subject, are disclosed. Therapies designed to prevent formation and / or reduce the size of biofilms in a subject identified to be at increased risk of cancer based upon detection of biofilms and / or biofilm-associated microbes are disclosed. In particular embodiments, the invention provides for identification of a subject at elevated risk of developing or having colorectal cancer and / or a colorectal adenoma, based upon detection of a biofilm and / or biofilm-associated bacteria within the gastrointestinal tract of the subject (optionally, within a biopsy specimen and / or stool sample of such subject). Therapies involving administration of an antibiotic agent and / or a probiotic agent to a subject, to prevent or reduce biofilm formation within the gastrointestinal tract of the subject, optionally provided in combination with additional cancer therapy, are also disclosed.
Owner:THE JOHN HOPKINS UNIV SCHOOL OF MEDICINE

Processes for producing polyalkylene carbonates

InactiveUS20110218321A1Inhibit depolymerizationHigh purityIon exchangeChemistry
Production of polyalkylene carbonates via polymerization of carbon dioxide with at least one epoxide of the general formula (I):where R re mutually independently H, halogen, NO2, CN, COOR′ or C1-20-hydrocarbon moiety, which can have substitution, where one of the moieties R can also be OH, and where two moieties R can together form a C3-5-alkylene moiety, R′ is H or C1-20-hydrocarbon moiety, which can have substitution; n a zinc salt of C4-8-alkanedicarboxylic acids as catalysts, where a carboxylic acid or an acidic ion exchanger and a non-water-miscible organic solvent which dissolves the polyalkylene carbonate are admixed with the reaction mixture obtained after the reaction, and the organic phase is washed with water, and the polyalkylene carbonate is optionally obtained from the organic phase.
Owner:BASF SE

Immobilized maleic acid cis-trans isomerase and preparation method and application thereof

The invention discloses immobilized maleic acid cis-trans isomerase and a preparation method and application thereof, and belongs to the technical fields of enzymology and enzyme engineering and the field of biochemical industries. According to the immobilized maleic acid cis-trans isomerase and the preparation method and application thereof, R5 peptide fragments are connected to the N ends of the maleic acid cis-trans isomerase, R5-MaiA is crosslinked through glutaraldehyde, embedding is conducted on the crosslinked R5-MaiA by utilizing silicon reaction liquid, and immobilization of the maleic acid cis-trans isomerase is completed. The immobilized maleic acid cis-trans isomerase (R5-MI-CLEA-Si) with high stability is obtained through the method which is low in cost and easy to operate, the optimum reaction temperature of the immobilized isomerase is 55 DEG C, and the optimum reaction pH is 7.7; on the condition that the temperature is 55 DEG C, the half-life period of the immobilized isomerase is 4 h, the half-life period of the free isomerase is 0.5 h, the stability of the immobilized isomerase is eight times of that of the free isomerase, and after a catalytic reaction is repeated for eight times, the enzyme activity of the immobilized isomerase can be still retained at 75%.
Owner:JIANGNAN UNIV

Method to Manufacture PLA Using a New Polymerization Catalyst

ActiveUS20160075821A1Good and even improved polymerizing propertyImprove thermal stabilityGroup 4/14 organic compounds without C-metal linkagesHalogenLactide
The invention relates to a method for manufacturing polylactide, comprising the steps of mixing lactide and a metal-coordination compound as polymerization catalyst to obtain a reaction mixture, polymerizing the lactide in liquid phase at a temperature of at least 150° C. to form polylactide in liquid phase and allowing the polylactide to solidify, characterized in that the polymerization catalyst comprises a metal-ligand coordination compound whereby the parent ligand answers the formula (I), whereby R represents an H atom, an aliphatic group, a halide atom or a nitro group and the metal is at least one of Zr and Hf. The invented catalysts show kinetics which is comparable to the kinetics of the known Sn-octoate catalyst.
Owner:PURAC BIOCHEM

Injectable hydrogel with antibacterial, antioxidant and hemostatic effects as well as preparation method and application of injectable hydrogel

The invention relates to injectable hydrogel with antibacterial, antioxidant and hemostatic effects and a preparation method and application thereof, the preparation method comprises the following steps: mixing an oxidized hyaluronic acid solution and a tannic acid solution, then mixing with a quaternized chitosan solution, and carrying out Schiff base reaction polymerization to obtain the injectable hydrogel. The hydrogel overcomes the defects that hyaluronic acid chitosan hydrogel in the prior art is poor in mechanical strength, rapid in degradation and the like; gel is formed in situ through Schiff base reaction, a cross-linking agent is not needed, and the method is green and safe; the device can be used for injection at a wound part, and has strong adaptability to wounds with irregular shapes; and the gel is degradable, so that a secondary operation is avoided. The polyphenol free radical scavenging activity of the tannic acid can effectively inhibit wound secondary oxidative stress injury caused by ROS (reactive oxygen species) and is beneficial to wound antibiosis and inflammation diminishing, meanwhile, the tannic acid can coagulate damaged collagen and provide an effective in-vivo hemostatic effect, and more importantly, after the tannic acid is introduced, the mechanical strength of the gel can be further enhanced.
Owner:SURGSCI SHENZHEN MEDICAL TECH CO LTD

A kind of immobilized maleate cis-trans isomerase and its preparation method and application

The invention discloses immobilized maleic acid cis-trans isomerase and a preparation method and application thereof, and belongs to the technical fields of enzymology and enzyme engineering and the field of biochemical industries. According to the immobilized maleic acid cis-trans isomerase and the preparation method and application thereof, R5 peptide fragments are connected to the N ends of the maleic acid cis-trans isomerase, R5-MaiA is crosslinked through glutaraldehyde, embedding is conducted on the crosslinked R5-MaiA by utilizing silicon reaction liquid, and immobilization of the maleic acid cis-trans isomerase is completed. The immobilized maleic acid cis-trans isomerase (R5-MI-CLEA-Si) with high stability is obtained through the method which is low in cost and easy to operate, the optimum reaction temperature of the immobilized isomerase is 55 DEG C, and the optimum reaction pH is 7.7; on the condition that the temperature is 55 DEG C, the half-life period of the immobilized isomerase is 4 h, the half-life period of the free isomerase is 0.5 h, the stability of the immobilized isomerase is eight times of that of the free isomerase, and after a catalytic reaction is repeated for eight times, the enzyme activity of the immobilized isomerase can be still retained at 75%.
Owner:JIANGNAN UNIV

Diketone derivative as well as preparation method and application thereof

InactiveCN106188039AAvoid depolymerizationRegulating Dynamic StabilityNervous disorderOrganic chemistryBromineKetone
The invention discloses a diketone derivative, as well as a preparation method and application thereof, and belongs to the technical field of biological medicines. The derivative comprises compounds in the general formula I and pharmaceutically-acceptable salt, wherein X is C or N; Y is C or N; R1 is one of hydrogen, chlorine, bromine or thiophene; R2 is one of hydrogen, isopropyl or methoxy. The most of compounds of the diketone derivative not only has an inhibiting effect on tau protein polymerization, but also plays a role in stabilizing microtubulin; the diketone derivative can be effectively used for treating the Alzheimer's disease.
Owner:GUANGDONG UNIV OF TECH
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products